{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:45:21Z","timestamp":1762875921263,"version":"3.37.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["RP-PG-0610-10048"],"award-info":[{"award-number":["RP-PG-0610-10048"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13063-017-2253-4","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T09:00:32Z","timestamp":1508835632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3491-0083","authenticated-orcid":false,"given":"George","family":"Salaminios","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Ades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Araya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine S.","family":"Button","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Churchill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Croudace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Derrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padraig","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Dowrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Gilbody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Hollingworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivien","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Kendrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daphne","family":"Kounali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Lanham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Malpass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim J.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Riozzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jude","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicky J.","family":"Welton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Wiles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glyn","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,24]]},"reference":[{"key":"2253_CR1","first-page":"1","volume-title":"Adult psychiatric morbidity in England 2007: results of a household survey","author":"S McManus","year":"2009","unstructured":"McManus S, Meltzer H, Brugha T, Bebbington P, Jenkins R. Adult psychiatric morbidity in England 2007: results of a household survey. Leeds: NHS Information Centre; 2009. p. 1\u2013274."},{"key":"2253_CR2","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.1989.03430070062031","volume":"262","author":"KB Wells","year":"1989","unstructured":"Wells KB, Stewart A, Hays RD, Burman A, Rogers W, Daniels M, et al. The functioning and well-being of depressed patients: results from the medical outcomes study. JAMA. 1989;262:914\u20139.","journal-title":"JAMA"},{"issue":"9859","key":"2253_CR3","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","volume":"380","author":"CJ Murray","year":"2012","unstructured":"Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197\u2013223.","journal-title":"Lancet"},{"issue":"11","key":"2253_CR4","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","volume":"3","author":"CD Mathers","year":"2006","unstructured":"Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.","journal-title":"PLoS Med"},{"key":"2253_CR5","doi-asserted-by":"crossref","first-page":"b750","DOI":"10.1136\/bmj.b750","volume":"338","author":"T Kendrick","year":"2009","unstructured":"Kendrick T, Dowrick C, McBride A, Howe A, Clarke P, Maisey S, et al. Management of depression in UK general practice in relation to scores on depression severity questionnaires: analysis of medical record data. BMJ. 2009;338:b750.","journal-title":"BMJ"},{"key":"2253_CR6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jad.2015.06.052","volume":"186","author":"T Kendrick","year":"2015","unstructured":"Kendrick T, Stuart B, Newell C, Geraghty AW, Moore M. Did NICE guidelines and the Quality Outcomes Framework change GP antidepressant prescribing in England? Observational study with time trend analyses 2003\u20132013. J Affect Disord. 2015;186:171\u20137.","journal-title":"J Affect Disord"},{"key":"2253_CR7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13063-016-1199-2","volume":"17","author":"D Tallon","year":"2016","unstructured":"Tallon D, Wiles N, Campbell J, Chew-Graham C, Dickens C, Macleod U, et al. Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial. Trials. 2016;17:66.","journal-title":"Trials"},{"key":"2253_CR8","unstructured":"Prescribing and Medicines Team, H.a.S.C.I.C. Prescriptions dispensed in the community: England 2004-14. NHS Digital; 2015."},{"key":"2253_CR9","unstructured":"OECD. Health at a glance 2013: OECD indicators. OECD publishing; 2013."},{"key":"2253_CR10","doi-asserted-by":"crossref","unstructured":"Mars B, Heron J, Kessler D, Davies NM, Martin, RM, Thomas KH, et al. Influences on antidepressant prescribing trends in the UK: 1995\u20132011. Social psychiatry and psychiatric epidemiology. 2017; 52(2):193-200.","DOI":"10.1007\/s00127-016-1306-4"},{"issue":"5","key":"2253_CR11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1192\/bjp.bp.115.166975","volume":"209","author":"RL McCrea","year":"2016","unstructured":"McCrea RL, Sammon CJ, Nazareth I, Petersen I. Initiation and duration of selective serotonin reuptake inhibitor prescribing over time: UK cohort study. Br J Psychiatry. 2016;209(5):421\u20136.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"2253_CR12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2009.1943","volume":"303","author":"JC Fournier","year":"2010","unstructured":"Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010;303(1):47\u201353.","journal-title":"JAMA"},{"issue":"1","key":"2253_CR13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00004714-200202000-00007","volume":"22","author":"A Khan","year":"2002","unstructured":"Khan A, Leventhal RM, Khan SR, Brown WA. Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database. J Clin Psychopharmacol. 2002;22(1):40\u20135.","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"2253_CR14","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1371\/journal.pmed.0050045","volume":"5","author":"I Kirsch","year":"2008","unstructured":"Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008;5(2):e45.","journal-title":"PLoS Med"},{"issue":"5","key":"2253_CR15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1192\/bjp.bp.115.173906","volume":"209","author":"J Rabinowitz","year":"2016","unstructured":"Rabinowitz J, Werbeloff N, Mandel FS, Menard F, Marangell L, Kapur S. Initial depression severity and response to antidepressants v. placebo: patient-level data analysis from 34 randomised controlled trials. Br J Psychiatry. 2016;209(5):427\u20138.","journal-title":"Br J Psychiatry"},{"key":"2253_CR16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1192\/bjp.bp.109.076448","volume":"198","author":"C Barbui","year":"2011","unstructured":"Barbui C, Cipriani A, Patel V, Ayuso-Mateos JL, van Ommeren M. Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br J Psychiatry. 2011;198:11\u20136.","journal-title":"Br J Psychiatry"},{"key":"2253_CR17","first-page":"CD004047","volume":"3","author":"LM Silva de","year":"2003","unstructured":"de Silva LM, Hotopf M. A comparison of active drugs for the treatment of dysthymia. Cochrane Database Syst Rev. 2003;3:CD004047.","journal-title":"Cochrane Database Syst Rev"},{"key":"2253_CR18","unstructured":"National Institute for Health and Care Excellence: Clinical Guidlines. London: The British Psychological Society and The Royal College of Psychiatrists; 2004."},{"issue":"9690","key":"2253_CR19","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(09)60879-5","volume":"374","author":"AJ Mitchell","year":"2009","unstructured":"Mitchell AJ, Vaze A, Rao S. Clinical diagnosis of depression in primary care: a meta-analysis. Lancet. 2009;374(9690):609\u201319.","journal-title":"Lancet"},{"issue":"3","key":"2253_CR20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00004850-200105000-00001","volume":"16","author":"H-U Wittchen","year":"2001","unstructured":"Wittchen H-U, H\u00f6fler M, Meister W. Prevalence and recognition of depressive syndromes in German primary care settings: poorly recognized and treated? Int Clin Psychopharmacol. 2001;16(3):121\u201335.","journal-title":"Int Clin Psychopharmacol"},{"issue":"9","key":"2253_CR21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"key":"2253_CR22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1017\/S0033291700030415","volume":"22","author":"G Lewis","year":"1992","unstructured":"Lewis G, Pelosi AJ, Araya R, Dunn G. Measuring psychiatric disorder in the community: a standardised assessment for use by lay interviewers. Psychol Med. 1992;22:465\u201386.","journal-title":"Psychol Med"},{"issue":"2","key":"2253_CR23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1192\/bjp.bp.108.051193","volume":"195","author":"CJ Harmer","year":"2009","unstructured":"Harmer CJ, Goodwin GM, Cowen PJ. Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br J Psychiatry. 2009;195(2):102\u20138.","journal-title":"Br J Psychiatry"},{"issue":"7","key":"2253_CR24","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1176\/appi.ajp.161.7.1256","volume":"161","author":"CJ Harmer","year":"2004","unstructured":"Harmer CJ, Shelley NC, Cowen PJ, Goodwin GM. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry. 2004;161(7):1256\u201363.","journal-title":"Am J Psychiatry"},{"issue":"10","key":"2253_CR25","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1176\/appi.ajp.2009.09020149","volume":"166","author":"CJ Harmer","year":"2009","unstructured":"Harmer CJ, O\u2019Sullivan U, Favaron E, Massey-Chase R, Ayres R, Reinecke A, et al. Effect of acute antidepressant administration on negative affective bias in depressed patients. Am J Psychiatry. 2009;166(10):1178\u201384.","journal-title":"Am J Psychiatry"},{"key":"2253_CR26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/jech.48.2.207","volume":"48","author":"G Lewis","year":"1994","unstructured":"Lewis G. Assessing psychiatric disorder with a human interviewer or a computer. J Epidemiol Community Health. 1994;48:207\u201310.","journal-title":"J Epidemiol Community Health"},{"key":"2253_CR27","unstructured":"Thomas HV, Lewis G, Sharp D, Watson M, Bell TS, Lyons I, et al. Computerised patient-specific guidelines for management of common mental disorder in primary care: a randomised controlled trial. Br J Gen Pract. 2004;54(508):832-7."},{"issue":"11","key":"2253_CR28","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archpsyc.63.11.1217","volume":"63","author":"MJ Taylor","year":"2006","unstructured":"Taylor MJ, Freemantle N, Geddes JR, Bhagwagar Z. Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch Gen Psychiatry. 2006;63(11):1217\u201323.","journal-title":"Arch Gen Psychiatry"},{"issue":"9665","key":"2253_CR29","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","volume":"373","author":"A Cipriani","year":"2009","unstructured":"Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet. 2009;373(9665):746\u201358.","journal-title":"Lancet"},{"key":"2253_CR30","doi-asserted-by":"crossref","unstructured":"Beck AT, Steer RA, & Brown, GK. Manual for the Beck Depression Inventory-II. San Antonio: Psychological Corporation; 1996.","DOI":"10.1037\/t00742-000"},{"issue":"3","key":"2253_CR31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"JE Ware Jr","year":"1996","unstructured":"Ware Jr JE, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220\u201333.","journal-title":"Med Care"},{"key":"2253_CR32","doi-asserted-by":"crossref","unstructured":"Devlin NJ, Brooks R. EQ-5D and the EuroQol Group: Past, Present and Future. Appl Health Econ Health Policy. 2017:1\u201311.","DOI":"10.1007\/s40258-017-0310-5"},{"issue":"10","key":"2253_CR33","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137.","journal-title":"Arch Intern Med"},{"key":"2253_CR34","doi-asserted-by":"crossref","unstructured":"Guitart-Masip M, Economides M, Huys QJ, Frank MJ, Chowdhury R, Duzel E, et al. Differential, but not opponent, effects of L-DOPA and citalopram on action learning with reward and punishment. Psychopharmacology. 2014;231(5):955-66.","DOI":"10.1007\/s00213-013-3313-4"},{"key":"2253_CR35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(12)61552-9","volume":"381","author":"N Wiles","year":"2013","unstructured":"Wiles N, Thomas L, Abel A, Ridgway N, Turner N, Campbell J, et al. Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial. Lancet. 2013;381:375\u201384.","journal-title":"Lancet"},{"key":"2253_CR36","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1192\/bjp.bp.110.082727","volume":"198","author":"G Lewis","year":"2011","unstructured":"Lewis G, Mulligan J, Wiles N, Cowen P, Craddock N, Ikeda M, et al. Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial. Br J Psychiatry. 2011;198:464\u201371.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"2253_CR37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1741-7015-8-18","volume":"8","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8(1):18.","journal-title":"BMC Med"},{"key":"2253_CR38","unstructured":"Hardin JW, Hilbe JM, Hilbe J. Generalized linear models and extensions. Stata press; 2007."},{"key":"2253_CR39","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-3242-6","volume-title":"Generalised linear models II","author":"P McCullagh","year":"1989","unstructured":"McCullagh P, Nelder J. Generalised linear models II. London: Chapman and Hall; 1989."},{"key":"2253_CR40","volume-title":"Evaluation and validation of social and psychological markers in randomised trials of complex interventions in mental health: a methodological research programme","author":"G Dunn","year":"2015","unstructured":"Dunn G, Emsley R, Liu H, Landau S, Green J, White I, et al. Evaluation and validation of social and psychological markers in randomised trials of complex interventions in mental health: a methodological research programme. 2015."},{"key":"2253_CR41","unstructured":"Joint Formulary Committee. British National Formulary. London: BMJ Group and Pharmaceutical Press; 2008."},{"key":"2253_CR42","unstructured":"Curtis L. Unit costs of health and social care 2009. PSSRU, University of Kent; 2009."},{"key":"2253_CR43","unstructured":"Department of, H. National schedule of reference costs 2009-10 for NHS Trusts and PCTs combined. 2011. Available from: http:\/\/www.dh.gov.uk\/en\/Publicationsandstatistics\/Publications\/PublicationsPolicyAndGuidance\/DH_123459 ."},{"key":"2253_CR44","volume-title":"Valuing health-related quality of life: an EQ-5D-5L value set for England","author":"N Devlin","year":"2016","unstructured":"Devlin N, Shah K, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of life: an EQ-5D-5L value set for England. 2016."},{"issue":"11","key":"2253_CR45","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/sim.789","volume":"20","author":"AR Willan","year":"2001","unstructured":"Willan AR, Lin D. Incremental net benefit in randomized clinical trials. Stat Med. 2001;20(11):1563\u201374.","journal-title":"Stat Med"},{"issue":"9","key":"2253_CR46","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2165\/00019053-200826090-00004","volume":"26","author":"C McCabe","year":"2008","unstructured":"McCabe C, Claxton K, Culyer AJ. The NICE cost-effectiveness threshold. Pharmacoeconomics. 2008;26(9):733\u201344.","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"2253_CR47","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/JOM.0000000000000130","volume":"56","author":"JS Hoch","year":"2014","unstructured":"Hoch JS, Dewa CS. Advantages of the net benefit regression framework for economic evaluations of interventions in the workplace: a case study of the cost-effectiveness of a collaborative mental health care program for people receiving short-term disability benefits for psychiatric disorders. J Occup Environ Med. 2014;56(4):441\u20135.","journal-title":"J Occup Environ Med"},{"issue":"7476","key":"2253_CR48","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/bmj.329.7476.1233","volume":"329","author":"J Coast","year":"2004","unstructured":"Coast J. Is economic evaluation in touch with society\u2019s health values? BMJ. 2004;329(7476):1233.","journal-title":"BMJ"},{"issue":"1","key":"2253_CR49","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"15","key":"2253_CR50","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1017\/S0033291715001270","volume":"45","author":"KS Button","year":"2015","unstructured":"Button KS, Kounali D, Thomas L, Wiles NJ, Peters TJ, Welton NJ, et al. Minimal clinically important difference on the Beck Depression Inventory\u2013II according to the patient\u2019s perspective. Psychol Med. 2015;45(15):3269\u201379.","journal-title":"Psychol Med"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-017-2253-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T22:44:32Z","timestamp":1570229072000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-017-2253-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,24]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2253"],"URL":"https:\/\/doi.org\/10.1186\/s13063-017-2253-4","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2017,10,24]]},"article-number":"496"}}